Bloomberg with this ICYMI - Imperial College London's vaccine
- backed by $52 million in U.K. funding along with more in donations
- work is based on technology called self-amplifying RNA
- If the vaccine yields a promising immune response, larger trials would begin later in the year with about 6,000 volunteers
Here is the hopium link for more
